Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Citation
H.R. 875, Food Safety Modernization Act of 2009
Study
Pharmaceutical Evolution
Albert I. Wertheimer and Thomas M. Santella explain the advantages of incremental innovation in drug development. Photo: CC <a href="http://www.flickr.com/photos/joethorn/86495698/">Joe Thorn</a>.
Newsletter
Cancer Treatment, Global Warming Doublespeak and Counting All the Votes in NY
Shares of Dendreon Corp. rise as analysts look forward to new data on its experimental prostate cancer drug, Provenge. Public relations practitioners complain of scientists…
Newsletter
Cancer Drugs, Voting Rights and Cap and Trade Controversy
Author Virginia Postrel details her successful battle against breast cancer. The Justice Department re-considers whether the proposed D.C. voting rights bill is constitutional. States with…
Newsletter
Absurd Product Bans, Global Warming Legislation and Unsafe Organic Farming
Industry observers look to California to take the lead in ending the ban on online gambling. Reps. Henry Waxman and Ed Markey introduce sweeping new…
Op-Eds
Supreme Court Botches Preemption Case
SUPREME COURT BOTCHES PREEMPTION CASE…